Keywords: qlt, posts, 2nd-qtr, visudyne, sales, gain, canada

QLT posts 27% 2nd-qtr Visudyne sales gain

Article | 05 August 2002

Print This

Canada's QLT Inc reports that, for the three months ended June 30, 2002,sales of Visudyne (verteporfin), a treatment for age-related macular ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in